Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2375-2378

  Janson, Eva Tiensuu ^a   Stridsberg, Mats ^a   Gobl, Anders ^a   Westlin, Jan Erik ^a   Öberg, Kjell ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ANTIBODY; INTERFERON; MESSENGER RNA; OCTREOTIDE; PENTETREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ARTICLE; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; SCINTIGRAPHY;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOID TUMOR; CHO CELLS; CRICETINAE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL NEOPLASMS; LUNG NEOPLASMS; OCTREOTIDE; POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032100585     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chen, C., Vincent, J. D., and Clarke, I. J. Ion channels and the signal tranduction pathways in the regulation of growth hormone secretion. Trends Endocrinol. Metab., 5: 227-233, 1994.
2. Patel, Y. C., Greenwood, M., Panetta, R., Hukovic, N., Grigorakis, S., Robertson, L. A., and Srikant, C. B. Molecular biology of somatostatin receptor subtypes. Metabolism 45 Suppl. 1: 31-38, 1996.
3. Yamada Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., and Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA, 89: 251-255, 1992.
4. Yamada, Y., Reisine, T., Law, S. F., Ihara, Y., Kubota, A., Kagimoto, S., Seino, M., Seino, Y., Bell, G. I., and Seino, S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol., 6: 2136-2142, 1992.
5. Yamada, Y., Kagimoto, S., Kubota, A., Yasuda, K., Masuda, K., Someya, Y., Ihara, Y., Li, Q., Imura, H., Seino, S., and Seino, Y. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochym. Biophys. Res. Commun., 195: 844-852, 1993.
6. Bruns, C., Weckbecker, G., Raulf, F., Kaupmann, K., Schoeffter, P., Hoyer, D., and Lübbert, H. Molecular pharmacology of somatostatin-receptor subtypes. In: B. Wiedenmann, L. K. Kvols, R. Arnold, and E. O. Riecken (eds.), Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease, pp. 138-146. New York: Annals of the New York Academy of Sciences, 1994.
7. Reubi, J. C., Kvols, L. K., Waser, B., Nagorney, D. M., Heitz, P. U., Charboneau, J. W., Reading, C. C., and Moertel, C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res., 50: 5969-5977, 1990.
8. Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., and Hahn, R. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N. Engl. J. Med., 315: 663-666, 1986.
9. 1]Octreotide scintigraphy in patients with carcinoid tumors: the predictive value for somatostatin analogue treatment. Eur. J. Endocrinol., 131: 577-581, 1994.
10. Janson, E. T., Gobl, A., Kälkner, K. M., and Öberg, K. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. Cancer Res., 56: 2561-2565, 1996.
11. Fisher, W. E., Muscarella, P., O'Dorisio, T. M., O'Dorisio, S., Kim, J. A., Doran, T. A., Sabourin, C. L., and Schirmer, W. J. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery, 120: 234-241, 1996.
12. Schonbrunn, A., Gu, Y. Z., Dournard, P., Beaudet, A., Tannenbaum, G. S., and Brown, P. J. Somatostatin receptor subtypes: specific expression and signaling properties. Metabolism, 45 (Suppl. 1): 8-11, 1996.
13. O'Shaughnessy, D. J. Radioimmunoassay of gut regulatory peptides. In: S. R. Bloom and R. G. Long (eds.), Antibodies, pp. 9-20. London: W. B. Saunders Company, Ltd., 1982.
14. Vaitukaitis, J., Robbins, J. B., Nieschlag, E., and Ross, G. T. A method for producing specific antisera with small doses of immunogen. J. Clin. Endocrinol., 33: 988-991, 1971.
15. Gobl, A. E., Funa, K., and Alm, G. V. Different induction patterns of mRNA for IFN-α and -β in human mononuclear leukocytes after in vitra stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J. Immunol., 140: 3605-3609, 1988.
16. Ponte, P., Ng, S. Y., Engel, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res., 12: 1687-1696, 1984.
17. Eriksson, B., Janson, E. T., Bax, N. D. S., Mignon, M., Morant, R., Opolon, P., Rougier, P., and Öberg, K. The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours. Digestion. 57 (Suppl. 1): 77-80, 1996.
18. Kubota, A., Yamada, Y., Kagimoto, S., Shimatsu, A., Imamura, M., Tsuda, K., Imura, H., Seino, S., and Seino, Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J. Clin. Invest. 93: 1321-1325, 1994.
19. Coy, D. H., and Taylor, J. E. Receptor-specific somatostatin analogs: correlation with biological activity. Metabolism, 45 (Suppl. 1): 21-23, 1996.